Showing 201-220 of 7110 for: Cochrane Systematic Reviews Back
- Allergen injection immunotherapy for seasonal allergic rhinitis
Cochrane Systematic Reviews, 4-Nov-2008
Allergic rhinitis is the most common of the allergic diseases. Despite improved understanding of the pathophysiology of allergic rhinitis and advances in its pharmacological treatment, its prevalence has increased worldwide. For patients whose symptoms re
- Allergen-specific oral immunotherapy for peanut allergy
Cochrane Systematic Reviews, 14-Aug-2012
Peanut allergy is one of the most common forms of food allergy encountered in clinical practice. In most cases, it does not spontaneously resolve; furthermore, it is frequently implicated in acute life-threatening reactions. The current management of pea
- Allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia (ALL) in first complete remission
Cochrane Systematic Reviews, 9-Aug-2011
Consolidation chemotherapy, autologous hematopoietic cell transplantation (HCT) and allogeneic HCT represent potential treatment alternatives for post-remission therapy in adult acute lymphoblastic leukemia (ALL), but there is genuine uncertainty regardin
- Allogeneic stem cell transplantation versus conventional therapy for advanced primary cutaneous T-cell lymphoma
Cochrane Systematic Reviews, 13-Aug-2013
Primary cutaneous T-cell lymphomas (CTCL) belong to the group of non-Hodgkin lymphomas and usually run an indolent course. However, some patients progress to advanced tumour or leukaemic stages. To date, there is no cure for those cases. In the last few y
- Allopurinol for chronic gout
Cochrane Systematic Reviews, 17-Sep-2014
Allopurinol, a xanthine oxidase inhibitor, is considered one of the most effective urate-lowering drugs and is frequently used in the treatment of chronic gout.
- Allopurinol for chronic prostatitis
Cochrane Systematic Reviews, 31-Oct-2011
Chronic prostatitis is a condition that causes men substantial morbidity through the associated constellation of urinary symptoms, sexual dysfunction, and pelvic pain. The etiology of chronic prostatitis is unknown, and the many and varied treatments for
- Allopurinol for preventing mortality and morbidity in newborn infants with hypoxic-ischaemic encephalopathy
Cochrane Systematic Reviews, 13-Jun-2012
Delayed neuronal death following a perinatal hypoxic insult is due partly to xanthine oxidase-mediated production of cytotoxic free radicals. Evidence exists that allopurinol, a xanthine-oxidase inhibitor, reduces delayed cell death in experimental models
- Almitrine-Raubasine combination for dementia
Cochrane Systematic Reviews, 15-Feb-2011
Almitrine-raubasine combination (brand name Duxil), has been considered as an alternative treatment for dementia.
- Aloe vera for prevention and treatment of infusion phlebitis
Cochrane Systematic Reviews, 3-Jun-2014
Up to 80% of hospitalised patients receive intravenous therapy at some point during their admission. About 20% to 70% of patients receiving intravenous therapy develop phlebitis. Infusion phlebitis has become one of the most common complications in patien
- Aloe vera for treating acute and chronic wounds
Cochrane Systematic Reviews, 28-Dec-2011
Aloe vera is a cactus-like perennial succulent belonging to the Liliaceae Family that is commonly grown in tropical climates. Animal studies have suggested that Aloe vera may help accelerate the wound healing process.
- Alpha lipoic acid for dementia
Cochrane Systematic Reviews, 21-Jul-2008
Oxidative processes have been implicated in the pathogenesis of neurodegenerative dementias including Alzheimer's disease. Protecting the central nervous system against these damaging mechanisms may be a useful therapeutic approach. Alpha lipoic acid (ALA
- Alpha-1 proteinase inhibitor (a1PI) for preventing chronic lung disease in preterm infants
Cochrane Systematic Reviews, 5-Dec-2010
Inflammation of the pulmonary parenchyma is one of the important mechanisms implicated in development of chronic lung disease (CLD) in preterm neonates.
- Alpha-2 adrenergic agonists for the prevention of cardiac complications among patients undergoing surgery
Cochrane Systematic Reviews, 6-Aug-2009
The surgical stress response plays an important role on the pathogenesis of perioperative cardiac complications. Alpha-2 adrenergic agonists attenuate this response and may thereby prevent cardiac complications.
- Alpha-2 adrenergic agonists for the prevention of shivering following general anaesthesia
Cochrane Systematic Reviews, 6-Aug-2015
Shivering after general anaesthesia is common. It is unpleasant but can also have adverse physiological effects. Alpha-2 (a-2) adrenergic agonist receptors, which can lead to reduced sympathetic activity and central regulation of vasoconstrictor tone, are
- Alpha-2 agonists for long-term sedation during mechanical ventilation in critically ill patients
Cochrane Systematic Reviews, 19-Aug-2015
Sedation reduces patient levels of anxiety and stress, facilitates the delivery of care and ensures safety. Alpha-2 agonists have a range of effects including sedation, analgesia and antianxiety. They sedate, but allow staff to interact with patients and
- Alpha2-adrenergic agonists for the management of opioid withdrawal
Cochrane Systematic Reviews, 26-Mar-2014
Withdrawal is a necessary step prior to drug-free treatment or as the endpoint of long-term substitution treatment.
- Alpha-blockers as medical expulsive therapy for ureteral stones
Cochrane Systematic Reviews, 1-Apr-2014
Urinary stone disease is one of the most common reasons for patients visiting a urology practice, affecting about 5% to 10% of the population. Annual costs for stone disease have rapidly increased over the years and most patients with ureteral colic or ot
- Alpha-foetoprotein and/or liver ultrasonography for screening of hepatocellular carcinoma in patients with chronic hepatitis B
Cochrane Systematic Reviews, 31-Jul-2012
Chronic hepatitis B virus infection is a risk factor for development of hepatocellular carcinoma. Alpha-foetoprotein and liver ultrasonography are used to screen patients with chronic hepatitis B for hepatocellular carcinoma. It is uncertain whether scree
- Alpha-glucosidase inhibitors for people with impaired glucose tolerance or impaired fasting blood glucose
Cochrane Systematic Reviews, 3-Nov-2008
Alpha-glucosidase inhibitors (AGIs) reduce blood glucose levels and may thus prevent type 2 diabetes and cardiovascular disease in patients with impaired glucose tolerance (IGT). These possible effects, and the effects on quality of life, plasma lipids an
- Alpha-glucosidase inhibitors for type 2 diabetes mellitus
Cochrane Systematic Reviews, 2-Nov-2008
Alpha-glucosidase inhibitors such as acarbose or miglitol, have the potential to improve glycemic control in type 2 diabetes mellitus. The true value of these agents, especially in relation to diabetes related mortality and morbidity, has never been inves
